168 related articles for article (PubMed ID: 32991255)
1. Improved Anti-Prion Nucleic Acid Aptamers by Incorporation of Chemical Modifications.
Amato J; Mashima T; Kamatari YO; Kuwata K; Novellino E; Randazzo A; Giancola C; Katahira M; Pagano B
Nucleic Acid Ther; 2020 Dec; 30(6):414-421. PubMed ID: 32991255
[TBL] [Abstract][Full Text] [Related]
2. Screening of DNA aptamer against mouse prion protein by competitive selection.
Ogasawara D; Hasegawa H; Kaneko K; Sode K; Ikebukuro K
Prion; 2007; 1(4):248-54. PubMed ID: 19164908
[TBL] [Abstract][Full Text] [Related]
3. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
Macedo B; Cordeiro Y
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
[TBL] [Abstract][Full Text] [Related]
4. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
[TBL] [Abstract][Full Text] [Related]
5. DNA Aptamer Binding Octapeptide Repeat Region of Cellular Prion Protein.
Sheng J; Zhang N; Long Z; Zhang X; Zu S; Liu X; Shangguan D
Anal Chem; 2023 Dec; 95(50):18595-18602. PubMed ID: 38048047
[TBL] [Abstract][Full Text] [Related]
6. Development and structural determination of an anti-PrP
Mashima T; Lee JH; Kamatari YO; Hayashi T; Nagata T; Nishikawa F; Nishikawa S; Kinoshita M; Kuwata K; Katahira M
Sci Rep; 2020 Mar; 10(1):4934. PubMed ID: 32188933
[TBL] [Abstract][Full Text] [Related]
7. Aptamers to explore prion protein interactions with nucleic acids.
Marc D
Front Biosci (Landmark Ed); 2010 Jan; 15(2):550-63. PubMed ID: 20036833
[TBL] [Abstract][Full Text] [Related]
8. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids.
Meek KN; Rangel AE; Heemstra JM
Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179
[TBL] [Abstract][Full Text] [Related]
9. Conformational changes of prion protein and nucleic acid arising from their interaction and relation of the altered structures in causing prion disease.
Nandi PK
Mini Rev Med Chem; 2008 Jul; 8(8):784-9. PubMed ID: 18673134
[TBL] [Abstract][Full Text] [Related]
10. DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity.
Takemura K; Wang P; Vorberg I; Surewicz W; Priola SA; Kanthasamy A; Pottathil R; Chen SG; Sreevatsan S
Exp Biol Med (Maywood); 2006 Feb; 231(2):204-14. PubMed ID: 16446497
[TBL] [Abstract][Full Text] [Related]
11. In vitro selection of RNA aptamers against cellular and abnormal isoform of mouse prion protein.
Sekiya S; Nishikawa F; Noda K; Kumar PK; Yokoyama T; Nishikawa S
Nucleic Acids Symp Ser (Oxf); 2005; (49):361-2. PubMed ID: 17150783
[TBL] [Abstract][Full Text] [Related]
12. New approaches for the selection and evaluation of anti-prion organic compounds.
Cordeiro Y; Ferreira NC
Mini Rev Med Chem; 2015; 15(2):84-92. PubMed ID: 25723455
[TBL] [Abstract][Full Text] [Related]
13. Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.
Murakami K; Izuo N; Bitan G
J Biol Chem; 2022 Jan; 298(1):101478. PubMed ID: 34896392
[TBL] [Abstract][Full Text] [Related]
14. Anti-prion activity of an RNA aptamer and its structural basis.
Mashima T; Nishikawa F; Kamatari YO; Fujiwara H; Saimura M; Nagata T; Kodaki T; Nishikawa S; Kuwata K; Katahira M
Nucleic Acids Res; 2013 Jan; 41(2):1355-62. PubMed ID: 23180780
[TBL] [Abstract][Full Text] [Related]
15. Sensitive discrimination and detection of prion disease-associated isoform with a dual-aptamer strategy by developing a sandwich structure of magnetic microparticles and quantum dots.
Xiao SJ; Hu PP; Wu XD; Zou YL; Chen LQ; Peng L; Ling J; Zhen SJ; Zhan L; Li YF; Huang CZ
Anal Chem; 2010 Dec; 82(23):9736-42. PubMed ID: 21038863
[TBL] [Abstract][Full Text] [Related]
16. The role of RNA in mammalian prion protein conversion.
Gomes MP; Vieira TC; Cordeiro Y; Silva JL
Wiley Interdiscip Rev RNA; 2012; 3(3):415-28. PubMed ID: 22095764
[TBL] [Abstract][Full Text] [Related]
17. Prion protein PrP nucleic acid binding and mobilization implicates retroelements as the replicative component of transmissible spongiform encephalopathy.
Lathe R; Darlix JL
Arch Virol; 2020 Mar; 165(3):535-556. PubMed ID: 32025859
[TBL] [Abstract][Full Text] [Related]
18. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
19. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acid aptamers as adjuncts to vaccine development.
Becker KC; Becker RC
Curr Opin Mol Ther; 2006 Apr; 8(2):122-9. PubMed ID: 16610764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
